Skip to content

A test of a deodorant device on the protection of flu

Double-blind sham device-controlled multi-center crossover trial of chlorine dioxide gas on the protective effect against respiratory infections - Cleverin test

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1092220033
Enrollment
1500
Registered
2009-10-13
Start date
2009-10-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory infections (common cold, influenza, bronchitis, pharyngitis, laryngitis and pneumonia)

Interventions

Intervention type:DEVICE Name of intervention:Low-concentration chlorine dioxide gas Dose form / Japanese Medical Device Nomenclature:NOT APPLICABLE Route of administration / Site of application:OTHE

Sponsors

Taiko Pharmaceutical Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Those who agree with the aim of this study.

Exclusion criteria

Exclusion criteria: Those who do not agree with the aim of this study.

Design outcomes

Primary

MeasureTime frame
Number of the incidence of respiratory infections

Secondary

MeasureTime frame
Deodorant effect of rooms.

Countries

Japan

Contacts

Public ContactNorio Ogata

Taiko Pharmaceutical Co., Ltd.

ogata@seirogan.co.jp+81-6-6382-3100

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026